82 



that are coming in from Canada, what levels you would consider 

 for rejection, and we are a little concerned about how that factors 

 into FDA's regulatory scheme of vomitoxin here in the United 

 States. 



They, of course, are going with advisory levels right now rather 

 than action levels, which are more stringent, and if there is some 

 kind of a rejection level set up, would that somehow affect the reg- 

 ulatory structure here in the United States, and adversely affect 

 our producers because of that. I just raise that concern, because it 

 seems to me if you are going to institute some kind of a screening 

 process, you have to have some levels in mind at which you are 

 going to reject grain. 



Mr. POMEROY. As cosponsor of that bill, I appreciate that point. 

 I believe that the overriding concern is to identify the quality of the 

 Canadian grain coming in. The issue of whether or not elevating 

 concern with Canadian vomitoxin-affected wheat inadvertently im- 

 pacts our own wheat to our disadvantage is a concern that we have 

 as the bill moves forward. Information or questions that you might 

 have as to the wisdom of this approach in light of that, we would 

 sure welcome. 



Mr. Keith. Thank you. 



Mr. Johnson. I want to thank members of this panel for your 

 insights and also your patience throughout the course of the day. 

 I think it has made a very valuable contribution to the hearing 

 record. With that, this hearing is adjourned. 



[Whereupon, at 1:45 p.m., the subcommittee was adjourned, to 

 reconvene, subject to the call of the Chair.] 



[Material submitted for inclusion in the record follows:] 



